Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TMDX |
---|---|---|
09:32 ET | 15932 | 82.47 |
09:33 ET | 4154 | 82.44 |
09:35 ET | 4400 | 82.15 |
09:37 ET | 1612 | 82.111835 |
09:39 ET | 1470 | 82.33 |
09:42 ET | 2712 | 82.53 |
09:44 ET | 4563 | 82.93 |
09:46 ET | 1616 | 82.7401 |
09:48 ET | 4404 | 82.63 |
09:50 ET | 3946 | 82.21 |
09:51 ET | 1442 | 82.295 |
09:53 ET | 5818 | 82.2601 |
09:55 ET | 2416 | 82.385 |
09:57 ET | 3833 | 82.4025 |
10:00 ET | 1450 | 82.2947 |
10:02 ET | 1600 | 82.5 |
10:04 ET | 1450 | 82.105 |
10:06 ET | 1777 | 82.32 |
10:08 ET | 2163 | 82.25 |
10:09 ET | 11497 | 82.08 |
10:11 ET | 15880 | 82.1 |
10:13 ET | 4468 | 82.19 |
10:15 ET | 8680 | 81.85 |
10:18 ET | 2553 | 81.94 |
10:20 ET | 16614 | 82.17 |
10:22 ET | 4265 | 81.9765 |
10:24 ET | 6439 | 82.53 |
10:26 ET | 5024 | 82.93 |
10:27 ET | 5899 | 83.1491 |
10:29 ET | 10668 | 83.6158 |
10:31 ET | 6543 | 83.5391 |
10:33 ET | 12465 | 84.08 |
10:36 ET | 5729 | 84.45 |
10:38 ET | 2275 | 84.38 |
10:40 ET | 3529 | 83.94 |
10:42 ET | 2399 | 83.81 |
10:44 ET | 3715 | 83.83 |
10:45 ET | 2771 | 84.065 |
10:47 ET | 1000 | 83.99 |
10:49 ET | 33221 | 84.3205 |
10:51 ET | 2869 | 84.34 |
10:54 ET | 1914 | 84.4402 |
10:56 ET | 3752 | 84.33 |
10:58 ET | 2831 | 84.226 |
11:00 ET | 1400 | 84.19 |
11:02 ET | 3849 | 84.2 |
11:03 ET | 1651 | 84.28 |
11:05 ET | 4700 | 84.4311 |
11:07 ET | 6667 | 84.66 |
11:09 ET | 4736 | 84.885 |
11:12 ET | 2700 | 84.81 |
11:14 ET | 3738 | 84.4 |
11:16 ET | 2899 | 84.41 |
11:18 ET | 250 | 84.41 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Transmedics Group Inc | 2.7B | 89.9x | --- |
LeMaitre Vascular Inc | 2.1B | 53.2x | +3.81% |
iRhythm Technologies Inc | 2.3B | -16.0x | --- |
Pacific Biosciences of California Inc | 665.0M | -1.6x | --- |
Cytek Biosciences Inc | 672.0M | -39.1x | --- |
AxoGen Inc | 611.4M | -38.5x | --- |
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
---|---|
Revenue (TTM) | $401.1M |
Shares Outstanding | 33.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.08 |
EPS | $0.94 |
Book Value | $4.20 |
P/E Ratio | 89.9x |
Price/Sales (TTM) | 6.9 |
Price/Cash Flow (TTM) | 54.6x |
Operating Margin | 7.84% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.